How are FTO and Blutzucker related?

The relationship between FTO and blood sugar is indirect, primarily mediated through the gene's well-established influence on body weight. Variants in the FTO gene (e.g., rs9939609) are among the most robustly replicated genetic markers for obesity in GWAS, and obesity is a major risk factor for insulin resistance and elevated blood glucose. Carriers of the risk allele tend to have a higher BMI, which in turn raises fasting glucose and HbA1c levels. Some studies suggest a small direct effect of FTO on glucose metabolism independent of adiposity, possibly via hypothalamic appetite regulation or altered energy expenditure, but the evidence is less consistent. The effect size is modest: risk allele carriers typically have ~0.1–0.2 mmol/L higher fasting glucose. Importantly, lifestyle factors—diet, physical activity, weight management—have a far greater impact on blood sugar than FTO genetics. A consumer DNA test for FTO should not be used alone to predict diabetes risk or guide clinical decisions. Evidence: human-strong (large GWAS meta-analyses). Caveat: the association is population-specific and modifiable by environment.